A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort studyGiulia Maggioni, Uwe Platzbecker, Daniele Dall’Olio et al.|The Lancet Haematology|2022Cited by 34
Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina Astrid Tentori, David A. Sallman, Lin P. Zhao et al.|HemaSphere|2024Cited by 11
Clinical Text Reports to Stratify Patients Affected with Myeloid Neoplasms Using Natural Language ProcessingGianluca Asti, Saverio D’Amico, Elisabetta Sauta et al.|Blood|2023Cited by 5
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)Luca Lanino, Vladan Vučinić, Anthony M. Hunter et al.|Blood|2024Cited by 3
Synthetic Histopathological Images Generation with Artificial Intelligence to Accelerate Research and Improve Clinical Outcomes in HematologyGianluca Asti, Matteo Giovanni Della Porta, Saverio D’Amico et al.|Blood|2023Cited by 2